Ignite Creation Date:
2025-12-24 @ 11:10 PM
Ignite Modification Date:
2026-04-15 @ 12:55 PM
Study NCT ID:
NCT02624869
Status:
COMPLETED
Last Update Posted:
2024-05-29
First Post:
2015-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Children With Inherited Elevated Low-density Lipoprotein Cholesterol (Familial Hypercholesterolemia)
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-10
Start Date Type:
ACTUAL
Primary Completion Date:
2021-06-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-01
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-22
First Submit QC Date:
None
Study First Post Date:
2015-12-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-11-15
Results First Submit QC Date:
None
Results First Post Date:
2022-01-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-10
Last Update Post Date:
2024-05-29
Last Update Post Date Type:
ACTUAL